The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Severe Acute Respiratory Syndrome Coronavirus—2 (SARS CoV-2) has resulted in the global spread of Coronavirus Disease 2019 (COVID-19) and an increase in complications including Acute Respiratory Distress Syndrome (ARDS). Due to the lack of therapeutic options for Acute Respiratory Distress Syndrome, recent attention has focused on differentiating hyper- and hypo-inflammatory phenotypes of ARDS to help define effective therapeutic strategies. Interleukin 8 (IL-8) is a pro-inflammatory cytokine that has a role in neutrophil activation and has been identified within the pathogenesis and progression of this disease. The aim of this review is to highlight the role of IL-8 as a biomarker and prognostic factor in modulating the hyperinflammatory response in ARDS. The crucial role of IL-8 in lung inflammation and disease pathogenesis might suggest IL-8 as a possible new therapeutic target to efficiently modulate the hyperinflammatory response in ARDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268 · cited 1×
“Additionally, patients with pancreatitis who developed ARDS have demonstrated significantly higher serum concentrations of IL-8, IL-6, and CD11b expression (indicative of neutrophil activation) compared to patients without ARDS (Browne and Pitchumoni, 2006).”
Acute Respiratory Distress Syndrome: The Berlin Definition
(2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 8,731
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Bellani, G., Laffey, J. G., Pham, T., Fan, E., Brochard, L., Esteban, A., Gattinoni, L., van Haren, F., Larsson, A., McAuley, D. F., et al. (2016) · JAMA · doi:10.1001/jama.2016.0291 · Cited by 5,766 · cited 2×
“ARDS has been previously identified as the cause of 10% of ICU admissions with up to 23% of patients requiring mechanical ventilation (Bellani et al., 2016).”
BackgroundImbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Prone positioning in severe acute respiratory distress syndrome.
Guérin, C., Reignier, J., Richard, J.-C., Beuret, P., Gacouin, A., Boulain, T., Mercier, E., Badet, M., Mercat, A., Baudin, O., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214103 · Cited by 4,040
Neutrophil extracellular traps in immunity and disease
Papayannopoulos, V. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.105 · Cited by 3,397 · cited 1×
“Beyond this antimicrobial action, NETs can also contribute to the pathogenesis of disease, due to either excessive formation or impaired removal, which can both produce toxic events for the host (Papayannopoulos, 2018).”
BackgroundFajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Fan, E., Del Sorbo, L., Goligher, E. C., Hodgson, C. L., Munshi, L., Walkey, A. J., Adhikari, N. K. J., Amato, M. B. P., Branson, R., Brower, R. G., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0548st · Cited by 1,630
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486 · cited 1×
“Several other studies have also demonstrated the potential contribution of NET formation in the inflammatory reaction, the immunopathology of COVID19 ARDS, and the presence of NETs in the lungs of patients who died from COVID-19 (Barnes et al., 2020; Radermecker et al., 2020).”
BackgroundMiddleton, E. A., He, X.-Y., Denorme, F., Campbell, R. A., Ng, D., Salvatore, S. P., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A. C., Loda, M., et al. (2020) · Blood · doi:10.1182/blood.2020007008 · Cited by 1,460
Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009575 · Cited by 1,439 · cited 1×
“The recent world-wide pandemic of Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in a dramatic increase in patients with acute respiratory failure and Acute Respiratory Distress Syndrome (ARDS), both of which are associated with increased mor…”
BackgroundCOVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
Gattinoni, L., Coppola, S., Cressoni, M., Busana, M., Rossi, S., & Chiumello, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0817le · Cited by 1,396
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288 · cited 1×
“…into the lungs of COVID-19 patients contribute to the production of proinflammatory cytokines and chemokines that result in cytokine storm leading to tissue damage, organ system dysfunction and progression to ARDS as well as mortality (Costela-Ruiz et al., 2020; Gómez-Rial et al., 2020).”
BackgroundAcute respiratory distress syndrome
Meyer, N. J., Gattinoni, L., & Calfee, C. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00439-6 · Cited by 1,144
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Structure and Functional Expression of a Human Interleukin-8 Receptor
Holmes, W. E., Lee, J., Kuang, W.-J., Rice, G. C., & Wood, W. I. (1991) · Science · doi:10.1126/science.1840701 · Cited by 1,090
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Ha, H., Debnath, B., & Neamati, N. (2017) · Theranostics · doi:10.7150/thno.15625 · Cited by 789 · cited 1×
“However, dysregulated signaling at the IL-8/CXCR1/2 axis has been identified as a possible cause to drive this immunopathology leading to an activated, prothrombotic, neutrophil phenotype characterized by degranulation and NET formation (Ha et al., 2017; Kaiser et al., 2021).”
BackgroundCalfee, C. S., Delucchi, K. L., Sinha, P., Matthay, M. A., Hackett, J., Shankar-Hari, M., McDowell, C., Laffey, J. G., O'Kane, C. M., McAuley, D. F., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30177-2 · Cited by 748 · cited 1×
“…pneumonia, aspiration lung injury, transfusion-related acute lung injury (TRALI) of blood products, trauma related and non-specific ARDS (Kiehl et al., 1998; Kurdowska et al., 2001; Parsons et al., 2005; McClintock et al., 2008; Agrawal et al., 2012; Cartin-Ceba et al., 2015; Bime et al., 2019).”
BackgroundParsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., & Wheeler, A. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000149854.61192.dc · Cited by 723 · cited 1×
“…pneumonia, aspiration lung injury, transfusion-related acute lung injury (TRALI) of blood products, trauma related and non-specific ARDS (Kiehl et al., 1998; Kurdowska et al., 2001; Parsons et al., 2005; McClintock et al., 2008; Agrawal et al., 2012; Cartin-Ceba et al., 2015; Bime et al., 2019).”
BackgroundCOVID-19 pneumonia: ARDS or not?
Gattinoni, L., Chiumello, D., & Rossi, S. (2020) · Critical Care · doi:10.1186/s13054-020-02880-z · Cited by 672
Characterization of the Inflammatory Response to Severe COVID-19 Illness
McElvaney, O. J., McEvoy, N. L., McElvaney, O. F., Carroll, T. P., Murphy, M. P., Dunlea, D. M., Ní Choileáin, O., Clarke, J., O’Connor, E., Hogan, G., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1583oc · Cited by 628 · cited 1×
“…IL-1β, IL-6, IL-8 and sTNFR1] have been demonstrated to be associated with severe COVID-19, including the presence of organ system failure (Del Valle et al., 2020; Li et al., 2020; McElvaney et al., 2020; Anderberg et al., 2021; Kaiser et al., 2021; Khalil et al., 2021; Meizlish et al., 2021).”
BackgroundPathological evidence of pulmonary thrombotic phenomena in severe COVID‐19
Dolhnikoff, M., Duarte‐Neto, A. N., de Almeida Monteiro, R. A., da Silva, L. F. F., de Oliveira, E. P., Saldiva, P. H. N., Mauad, T., & Negri, E. M. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14844 · Cited by 592 · cited 2×
“HuMax-IL-8 (BMS986253), is a human monoclonal antibody targeting IL-8 overexpressed in multiple cancer types, and able to reduce MDSCs (Dominguez et al., 2017).”
BackgroundImmunopathology of Hyperinflammation in COVID-19
Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516
Vascular occlusion by neutrophil extracellular traps in COVID-19
Leppkes, M., Knopf, J., Naschberger, E., Lindemann, A., Singh, J., Herrmann, I., Stürzl, M., Staats, L., Mahajan, A., Schauer, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102925 · Cited by 446
Radermecker, C., Detrembleur, N., Guiot, J., Cavalier, E., Henket, M., d’Emal, C., Vanwinge, C., Cataldo, D., Oury, C., Delvenne, P., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201012 · Cited by 349 · cited 1×
“Several other studies have also demonstrated the potential contribution of NET formation in the inflammatory reaction, the immunopathology of COVID19 ARDS, and the presence of NETs in the lungs of patients who died from COVID-19 (Barnes et al., 2020; Radermecker et al., 2020).”
BackgroundCytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J., & Pickkers, P. (2020) · JAMA · doi:10.1001/jama.2020.17052 · Cited by 333
Jafarzadeh, A., Chauhan, P., Saha, B., Jafarzadeh, S., & Nemati, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118102 · Cited by 327 · cited 1×
“However, in SARS-CoV-2 infection, infected monocytes and macrophages migrate to tissues and facilitate the spread of the virus (Gómez-Rial et al., 2020; Jafarzadeh et al., 2020).”
BackgroundA neutrophil activation signature predicts critical illness and mortality in COVID-19
Meizlish, M. L., Pine, A. B., Bishai, J. D., Goshua, G., Nadelmann, E. R., Simonov, M., Chang, C.-H., Zhang, H., Shallow, M., Bahel, P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003568 · Cited by 316
Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation
Adrover, J. M., Aroca-Crevillén, A., Crainiciuc, G., Ostos, F., Rojas-Vega, Y., Rubio-Ponce, A., Cilloniz, C., Bonzón-Kulichenko, E., Calvo, E., Rico, D., et al. (2020) · Nature Immunology · doi:10.1038/s41590-019-0571-2 · Cited by 282 · cited 1×
“Furthermore, in severe COVID-19 patients, immature and low-density neutrophils prevail with a greater propensity to release NETs, related to COVID-19 severity, which could explain a potential susceptibility towards progression of ARDS (Adrover et al., 2020).”
BackgroundHepatic platelet and leukocyte adherence during endotoxemia
Croner, R. S., Hoerer, E., Kulu, Y., Hackert, T., Gebhard, M.-M., Herfarth, C., & Klar, E. (2006) · Critical Care · doi:10.1186/cc3968 · Cited by 275
Qazi, B. S., Tang, K., & Qazi, A. (2011) · International Journal of Inflammation · doi:10.4061/2011/908468 · Cited by 272 · cited 1×
“Numerous studies indicate that IL-8 is expressed in various cell types including neutrophils, fibroblasts, epithelial cells, hepatocytes, alveolar macrophages, and endothelial cells (Qazi et al., 2011).”
BackgroundCell death mechanisms in eukaryotes
Nirmala, J. G., & Lopus, M. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09496-2 · Cited by 267
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine
Spadaro, S., Park, M., Turrini, C., Tunstall, T., Thwaites, R., Mauri, T., Ragazzi, R., Ruggeri, P., Hansel, T. T., Caramori, G., et al. (2019) · Journal of Inflammation · doi:10.1186/s12950-018-0202-y · Cited by 266 · cited 1×
“Patients with ARDS can be further classified into a hyperinflammatory phenotype based upon an influx of neutrophil activity that occurs after pulmonary insult leading to tissue injury (Spadaro et al., 2019).”
BackgroundChemokines and chemokine receptors during COVID-19 infection
Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 249
Phenotypes and personalized medicine in the acute respiratory distress syndrome
Matthay, M. A., Arabi, Y. M., Siegel, E. R., Ware, L. B., Bos, L. D. J., Sinha, P., Beitler, J. R., Wick, K. D., Curley, M. A. Q., Constantin, J.-M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06296-9 · Cited by 212
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU
Tan, E., Song, J., Deane, A. M., & Plummer, M. P. (2021) · Chest · doi:10.1016/j.chest.2020.10.014 · Cited by 185 · cited 1×
“The recent world-wide pandemic of Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in a dramatic increase in patients with acute respiratory failure and Acute Respiratory Distress Syndrome (ARDS), both of which are associated with increased mor…”
BackgroundDominguez, C., McCampbell, K. K., David, J. M., & Palena, C. (2017) · JCI Insight · doi:10.1172/jci.insight.94296 · Cited by 170 · cited 3×
“An exaggerated inflammatory response to SARS-CoV-2 is associated with disease severity and mortality (Gustine and Jones, 2021; Fajgenbaum and June, 2020).”
BackgroundBiomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury
McClintock, D., Zhuo, H., Wickersham, N., Matthay, M. A., & Ware, L. B. (2008) · Critical Care · doi:10.1186/cc6846 · Cited by 168
Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
Li, L., Li, J., Gao, M., Fan, H., Wang, Y., Xu, X., Chen, C., Liu, J., Kim, J., Aliyari, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.602395 · Cited by 164
Mikacenic, C., Moore, R., Dmyterko, V., West, T. E., Altemeier, W. A., Liles, W. C., & Lood, C. (2018) · Critical Care · doi:10.1186/s13054-018-2290-8 · Cited by 153
Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
Kaiser, R. W. J., Leunig, A., Pekayvaz, K., Popp, O., Joppich, M., Polewka, V., Escaig, R., Anjum, A., Hoffknecht, M., Gold, C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150862 · Cited by 140
Pathophysiology of pulmonary complications of acute pancreatitis
Browne, G. W. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7087 · Cited by 140 · cited 2×
“12:808797. doi: 10.3389/fphar.2021.808797 Frontiers in Pharmacology | www.frontiersin.org January 2022 | Volume 12 | Article 8087971 REVIEW published: 12 January 2022 doi: 10.3389/fphar.2021.808797 time and in the right amount (Calfee et al., 2018; Horie et al., 2020; Ware et al., 2020).”
BackgroundInfluentialTherapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice
Zarbock, A., Allegretti, M., & Ley, K. F. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.270 · Cited by 137 · cited 5×
“In a study designed to explore the possible role of autophagy in ALI induced by seawater, it was found that lung injury was correlated with increased levels of IL-8 in BALF (Liu et al., 2013).”
BackgroundInfluentialSelf-citationRole of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy
Rial, J. G., Calle, I. R., Salas, A., & Martinón‐Torres, F. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s258639 · Cited by 136
Meem, M., Modak, J. K., Mortuza, R., Morshed, M., Islam, M. S., & Saha, S. K. (2011) · PubMed Central · Cited by 135
Nassar, M. S., Bakhrebah, M. A., Meo, S. A., Alsuabeyl, M. S., & Zaher, W. A. (2018) · PubMed · doi:10.26355/eurrev_201808_15635 · Cited by 129
Sacchi, A., Grassi, G., Bordoni, V., Lorenzini, P., Cimini, E., Casetti, R., Tartaglia, E., Marchioni, L., Petrosillo, N., Palmieri, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03125-1 · Cited by 126 · cited 6×
“NETs induced by SARS-CoV-2 promote immunothrombosis, which subsequently contributes to lung cell death, resulting in massive neutrophil infiltration in the lungs as well as formation of NETs that are hypothesized to potentiate the development of ARDS (Middleton et al., 2020).”
BackgroundInfluentialZaid, Y., Doré, É., Dubuc, I., Archambault, A., Flamand, O., Laviolette, M., Flamand, N., Boilard, É., & Flamand, L. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.032 · Cited by 110 · cited 1×
“A crucial aspect seems to be that plasma inflammatory cytokines/chemokines show limited correlations with BALF cytokines/chemokines, implying that circulating inflammatory molecules may not be a reliable proxy of the inflammation occurring in the lungs of severe COVID-19 patients (Zaid et al., 2021).”
BackgroundEmerging pharmacological therapies for ARDS: COVID-19 and beyond
Horie, S., McNicholas, B., Rezoagli, E., Pham, T. O., Curley, G., McAuley, D. F., O’Kane, C. M., Nichol, A., dos Santos, C. C., Rocco, P. R. M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06141-z · Cited by 105
Discrete Steps in Binding and Signaling of Interleukin-8 with Its Receptor
Wu, L., Ruffing, N., Shi, X., Newman, W., Soler, D. F., Mackay, C. R., & Qin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31202 · Cited by 99 · cited 1×
“IL-8 mediates its biological effects through the binding to its cognate G-protein-coupled CXC chemokine receptors, CXCR1 and CXCR2, which activates a phosphorylation cascade to trigger chemotaxis and neutrophil activation as part of the inflammatory response (Holmes et al., 1991; Wu et al., 1996).”
BackgroundAnderberg, S. B., Luther, T., Berglund, M., Larsson, R. L., Rubertsson, S., Lipcsey, M., Larsson, A. O., Frithiof, R., & Hultström, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155389 · Cited by 98 · cited 3×
“Furthermore, IL-8 levels in BALF correlates negatively with arterial PaO2/FiO2 ratio.”
BackgroundCompartmental immunophenotyping in COVID-19 ARDS: A case series
Ronit, A., Berg, R. M. G., Bay, J. T., Haugaard, A. K., Ahlström, M. G., Burgdorf, K. S., Ullum, H., Rørvig, S. B., Kristiansen, K. T., Foss, N. B., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.09.009 · Cited by 97 · cited 3×
“Among these, IL-8 exhibits a notable compartmentalized response within the lungs that, when considering the cellular immune response, is consistent with the well-established role of IL-8 in the recruitment of neutrophils to the lungs during acute pulmonary inflammation (Ronit et al., 2021).”
BackgroundInfluentialAgrawal, A. T., Zhuo, H., Brady, S. E., Levitt, J. E., Steingrub, J. S., Siegel, M. D., Soto, G. J., Peterson, M. W., Chesnutt, M. S., Matthay, M. A., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00195.2012 · Cited by 96 · cited 1×
“BALF IL-8 concentrations have been significantly associated with mortality in sepsis, pneumonia, aspiration lung injury, transfusion-related acute lung injury (TRALI) of blood products, trauma related and non-specific ARDS (Kiehl et al., 1998; Kurdowska et al., 2001; Parsons et al., 2005; McClintock et al., 2008; Agra…”
BackgroundAnti-interleukin 8 Autoantibody:Interleukin 8 Complexes in the Acute Respiratory Distress Syndrome
Kurdowska, A., Noble, J. M., Steinberg, K. P., RUZINSKI, J. T., Hudson, L. D., & MARTIN, T. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2005109 · Cited by 93
Ma, A., Zhang, L., Ye, X., Chen, J., Yu, J., Zhuang, L., Weng, C., Petersen, F., Wang, Z., & Yu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626235 · Cited by 92 · cited 1×
“Elevated serum levels of IL-8 have been associated with longer duration of illness in patients with severe or critical COVID-19 (p 0.004) (Ma et al., 2021).”
BackgroundInfluentialPallister, I., Dent, C., & Topley, N. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00007 · Cited by 88
Development of a biomarker mortality risk model in acute respiratory distress syndrome
Bime, C., Casanova, N., Oita, R. C., Ndukum, J., Lynn, H., Camp, S. M., Lussier, Y., Abraham, I., Carter, D., Miller, E. J., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2697-x · Cited by 88 · cited 1×
“BALF IL-8 concentrations have been significantly associated with mortality in sepsis, pneumonia, aspiration lung injury, transfusion-related acute lung injury (TRALI) of blood products, trauma related and non-specific ARDS (Kiehl et al., 1998; Kurdowska et al., 2001; Parsons et al., 2005; McClintock et al., 2008; Agra…”
BackgroundCytokines and clinical predictors in distinguishing pulmonary transfusion reactions
Roubinian, N. H., Looney, M. R., Kor, D. J., Lowell, C. A., Gajic, O., Hubmayr, R. D., Gropper, M. A., Koenigsberg, M., Wilson, G. A., Matthay, M. A., et al. (2015) · Transfusion · doi:10.1111/trf.13021 · Cited by 83 · cited 1×
“In TRALI, elevated plasma levels of IL8 preceded lung injury (Roubinian et al., 2015).”
BackgroundLi, J., Liu, R., Cui, R., Feng, J., Jin, Y., Yu, Y., Chen, X., & Xu, R. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-2134 · Cited by 79
CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection
Tavares, L. P., Garcia, C. C., Machado, M. G., Queiroz‐Junior, C. M., Barthélémy, A., Trottein, F., Siqueira, M. M., Brandolini, L., Allegretti, M., Machado, A. V., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01799 · Cited by 74 · cited 2×
“These data suggests that modulation of the inflammatory response by blocking CXCR1/2 improves disease outcome during respiratory influenza and pneumococcal infections, without compromising the ability of the murine host to deal with infection (Tavares et al., 2017).”
BackgroundSelf-citationAlveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS
Bendib, I., Beldi‐Ferchiou, A., Schlemmer, F., Surénaud, M., Maître, B., Plonquet, A., Carteaux, G., Razazi, K., Godot, V., Hüe, S., et al. (2021) · Critical Care · doi:10.1186/s13054-020-03427-y · Cited by 73 · cited 1×
“In fact, chemokines like CXCL1 (GROα) and IL-8 were found to be 30 times more abundant in BALF than in plasma and 200 times more abundant than IL-6 and TNF-α; consistent with the levels of these chemotactic molecules, BALF was rich in neutrophils, lymphocytes and eosinophils (Bendib et al., 2021).”
BackgroundAnalysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq
Merza, M., Hwaiz, R. A., Hamad, B. K., Mohammad, K. A., Hama, H. A., & Karim, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250330 · Cited by 72
Hildebrand, F., Stuhrmann, M., van Griensven, M., Meier, S., Hasenkamp, S., Krettek, C., & Pape, H. (2007) · Cytokine · doi:10.1016/j.cyto.2007.03.008 · Cited by 67 · cited 1×
“It has also been observed that trauma patients have neutrophil infiltration within their lungs associated with elevated IL-8 concentrations in BALF, supporting a possible role in organ injury (Pallister et al., 2002; Hildebrand et al., 2007).”
BackgroundMoazed, F., Burnham, E. L., Vandivier, R. W., O’Kane, C. M., Shyamsundar, M., Hamid, U. I., Abbott, J., THICKETT, D. R., Matthay, M. A., McAuley, D. F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207886 · Cited by 66
Nagant, C., Ponthieux, F., Smet, J., Dauby, N., Doyen, V., Besse‐Hammer, T., Bels, D. D., Maillart, E., & Corazza, F. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.003 · Cited by 65
Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies
Ware, L. B., Matthay, M. A., & Mebazaa, A. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06232-x · Cited by 50
Lung histopathological findings in COVID-19 disease – a systematic review
Pannone, G., Caponio, V. C. A., Stefano, I. S. D., Ramunno, M. A., Meccariello, M., Agostinone, A., Pedicillo, M. C., Troiano, G., Zhurakivska, K., Cassano, T., et al. (2021) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00369-0 · Cited by 48
Kiehl, M. G., Ostermann, H., Thomas, M., Müller, C., Cassens, U., & Kienast, J. (1998) · Critical Care Medicine · doi:10.1097/00003246-199807000-00019 · Cited by 45
Chen, L., Wang, G., Tan, J., Cao, Y., Long, X., Luo, H., Tang, Q., Jiang, T., Wang, W., & Zhou, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00433-y · Cited by 45 · cited 1×
“The use of specific biomarkers in the management of COVID-19 patients may be useful to attenuate or prevent complications from the disease (Coperchini et al., 2020; Caruso et al., 2021).”
BackgroundA review of COVID-19 biomarkers and drug targets: resources and tools
Caruso, F. P., Scala, G., Cerulo, L., & Ceccarelli, M. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa328 · Cited by 43 · cited 1×
“Scoring cytokine storm by levels of MCP-3 and IL-8, accurately can stratify COVID-19 patients for high risk of mortality (Chen et al., 2020).”
BackgroundParticipation of autophagy in acute lung injury induced by seawater
Liu, Q., Zhou, D.-X., Lin, P., Gao, X., Pan, L., & Jin, F. (2013) · Experimental Lung Research · doi:10.3109/01902148.2013.845626 · Cited by 28
Stang, M.-B. L., Desenclos, J., Flamant, M., Chousterman, B. G., & Tabibzadeh, N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.613019 · Cited by 18
Metadata
- Authors
- Cesta, M. C., Zippoli, M., Marsiglia, C., Gavioli, E. M., Mantelli, F., Allegretti, M., & Balk, R. A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-01-12
- Volume
- 12
- Pages
- 808797-808797
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W4205879827
- Cited by
- 165
- References
- 78
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.